Re: Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

Journal of the National Cancer Institute

Volumn 106, Issue 9, 2014, Pages

  Bakinde, Nicolas ^a   Gbolahan, Olumide ^a   Ibraheem, Abiola ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; ANTINEOPLASTIC AGENT; PROTEOME; TRANSCRIPTOME;

CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; COMPARATIVE STUDY; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; WAIST HIP RATIO; CHEMISTRY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; NOTE;

ANTINEOPLASTIC AGENTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; TRANSCRIPTOME; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84927591610     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju253     Document Type: Letter

References (6)

1. Liu NQ, Stingl C, Look M P, et al. revealing an 11-Protein signature for Aggressive Triple-Negative Breast Cancer. J Natl Cancer Inst. 2014;106(2):1-10.
2. Mehtars. dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemo sensitivity of triplenegative breast cancer: a step toward reversing triple-negative paradox. J Clin Oncol. 2008;26(19):3286-3288; author reply 3288.
3. Brouckaert O, Wildiers H, Floris G, Nevin P. update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health. 2012;4:511-520.
4. Sturtz LA, Melley J, Mamula K, et al. outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer. BMC cancer. 2014;14 (1) 62.
5. Nak Y, Kim KS, Lee JE, et al. The 70-gene prognostic signature for korean breast cancer patients. J Breast Cancer. 2011;14(1):33-38.
6. Ishitobi M, Goranova TE, Komoike Y, et al. Clinical utility of the 70-gene MammaPrint profile in a Japanese population. Jpn J Clin Oncol. 2010. 40(6):508-512.